DeciBio Consulting (“DeciBio”), a precision medicine-focused strategy consulting and market intelligence firm, launched the DeciBio Market Intelligence Portal. The portal brings DeciBio’s Market Reports, DxBooks lab survey databases, Oncology Genomics Trackers, and Transcript Database into one subscription platform. It also introduces DeciChat, an AI assistant that performs cross-product querying and synthesis. Life science tools, diagnostics, and biopharma teams can ask a question and receive an answer drawn from across DeciBio’s research, with citations to the source data.

“Precision medicine is moving faster than traditional market research can track. And decisions that once took months of analysis now need to be made in weeks,” said Rebecca Burnham, PhD, Head of DeciBio’s Market Reports Division. “The Market Intelligence Portal and DeciChat give our clients direct access to the primary research that drives those decisions, in a form they can act on right away.”

DeciChat: One Question, Every Source

DeciChat helps teams get evidence-backed answers to the market questions behind their most important decisions, from sizing an opportunity to prioritizing markets or evaluating partners. Its AI agents search proprietary data from DeciBio’s precision medicine experts, then synthesize the findings into a single response. Each answer links back to the underlying report, dataset, or transcript, so teams can verify the numbers and insights and build on them in their own analyses.

“General-purpose AI tools are only as good as what they can find, and most precision medicine market data isn’t public,” said Andrew Stiegler, PhD, Head of DeciBio’s DxBooks Division. “DeciChat’s agents work directly on our private survey data, forecasts, and interview transcripts. Automated pipelines mean every new DxBook release, tracker update, and transcript is searchable as soon as the research is completed.”